Of clear relevance for potential therapeutic strategies, a recent report showed that loss of EP400 is synthetic lethal with perturbation of the SWI/SNF remodeler in cancer cell lines (46), a link supported by CRISPR screens and cancer patient data. The gene discussed is EP400; the disease is cancer.